nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ITGAL—cardiovascular system—attention deficit hyperactivity disorder	0.0862	0.0998	CbGeAlD
Lovastatin—ITGAL—midbrain—attention deficit hyperactivity disorder	0.0673	0.078	CbGeAlD
Lovastatin—ITGAL—cerebellum—attention deficit hyperactivity disorder	0.0521	0.0603	CbGeAlD
Lovastatin—ITGAL—brain—attention deficit hyperactivity disorder	0.0423	0.049	CbGeAlD
Lovastatin—PON3—brain—attention deficit hyperactivity disorder	0.0415	0.048	CbGeAlD
Lovastatin—HDAC2—forebrain—attention deficit hyperactivity disorder	0.0408	0.0472	CbGeAlD
Lovastatin—HMGCR—forebrain—attention deficit hyperactivity disorder	0.0368	0.0426	CbGeAlD
Lovastatin—HDAC2—cardiovascular system—attention deficit hyperactivity disorder	0.0345	0.0399	CbGeAlD
Lovastatin—HMGCR—cardiovascular system—attention deficit hyperactivity disorder	0.0311	0.036	CbGeAlD
Lovastatin—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.0287	0.0332	CbGeAlD
Lovastatin—HDAC2—midbrain—attention deficit hyperactivity disorder	0.0269	0.0312	CbGeAlD
Lovastatin—HMGCR—midbrain—attention deficit hyperactivity disorder	0.0243	0.0281	CbGeAlD
Lovastatin—HDAC2—nervous system—attention deficit hyperactivity disorder	0.0221	0.0256	CbGeAlD
Lovastatin—HDAC2—central nervous system—attention deficit hyperactivity disorder	0.0213	0.0247	CbGeAlD
Lovastatin—HDAC2—cerebellum—attention deficit hyperactivity disorder	0.0208	0.0241	CbGeAlD
Lovastatin—HMGCR—nervous system—attention deficit hyperactivity disorder	0.02	0.0231	CbGeAlD
Lovastatin—HMGCR—central nervous system—attention deficit hyperactivity disorder	0.0192	0.0223	CbGeAlD
Lovastatin—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0189	0.0219	CbGeAlD
Lovastatin—HMGCR—cerebellum—attention deficit hyperactivity disorder	0.0188	0.0218	CbGeAlD
Lovastatin—HDAC2—brain—attention deficit hyperactivity disorder	0.0169	0.0196	CbGeAlD
Lovastatin—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.0156	0.018	CbGeAlD
Lovastatin—HMGCR—brain—attention deficit hyperactivity disorder	0.0153	0.0177	CbGeAlD
Lovastatin—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.015	0.0174	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.015	0.0174	CbGeAlD
Lovastatin—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.0146	0.017	CbGeAlD
Lovastatin—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0134	0.0155	CbGeAlD
Lovastatin—SLCO1A2—brain—attention deficit hyperactivity disorder	0.0119	0.0138	CbGeAlD
Lovastatin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0096	0.0111	CbGeAlD
Lovastatin—CYP2C8—brain—attention deficit hyperactivity disorder	0.00831	0.00962	CbGeAlD
Lovastatin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00812	0.0094	CbGeAlD
Lovastatin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00737	0.00853	CbGeAlD
Lovastatin—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00725	0.00839	CbGeAlD
Lovastatin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00709	0.00821	CbGeAlD
Lovastatin—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00698	0.00808	CbGeAlD
Lovastatin—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00682	0.0079	CbGeAlD
Lovastatin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00634	0.00734	CbGeAlD
Lovastatin—CYP2D6—brain—attention deficit hyperactivity disorder	0.00554	0.00641	CbGeAlD
Lovastatin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00521	0.00604	CbGeAlD
Lovastatin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00502	0.00581	CbGeAlD
Lovastatin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00491	0.00568	CbGeAlD
Lovastatin—ABCB1—brain—attention deficit hyperactivity disorder	0.00398	0.00461	CbGeAlD
Lovastatin—HDAC2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00109	0.00797	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00109	0.00796	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00105	0.00772	CbGpPWpGaD
Lovastatin—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00103	0.00758	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00102	0.0075	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00099	0.00726	CbGpPWpGaD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—EP300—attention deficit hyperactivity disorder	0.000983	0.0072	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000966	0.00708	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000953	0.00698	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000952	0.00698	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000945	0.00693	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000942	0.0069	CbGpPWpGaD
Lovastatin—UGT1A3—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000939	0.00688	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000918	0.00673	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000882	0.00647	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00087	0.00638	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000861	0.00631	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00083	0.00608	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—EP300—attention deficit hyperactivity disorder	0.000822	0.00603	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—EP300—attention deficit hyperactivity disorder	0.000813	0.00596	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00081	0.00594	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00081	0.00594	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000804	0.00589	CbGpPWpGaD
Lovastatin—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000798	0.00585	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000792	0.00581	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000756	0.00554	CbGpPWpGaD
Lovastatin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000748	0.00548	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000744	0.00545	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.000739	0.00542	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—EP300—attention deficit hyperactivity disorder	0.000731	0.00536	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.000724	0.00531	CbGpPWpGaD
Lovastatin—HMGCR—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000716	0.00525	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00071	0.0052	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000701	0.00514	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000658	0.00482	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000653	0.00479	CbGpPWpGaD
Lovastatin—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000649	0.00476	CbGpPWpGaD
Lovastatin—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000648	0.00475	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000608	0.00446	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000596	0.00437	CbGpPWpGaD
Lovastatin—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000578	0.00424	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—EP300—attention deficit hyperactivity disorder	0.000577	0.00423	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000556	0.00408	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000553	0.00406	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000549	0.00403	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000549	0.00403	CbGpPWpGaD
Lovastatin—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000546	0.004	CbGpPWpGaD
Lovastatin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000532	0.0039	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STUB1—attention deficit hyperactivity disorder	0.000531	0.00389	CbGpPWpGaD
Lovastatin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000527	0.00386	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000509	0.00373	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000495	0.00363	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—EP300—attention deficit hyperactivity disorder	0.000483	0.00354	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000483	0.00354	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000478	0.0035	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000476	0.00349	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000472	0.00346	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000433	0.00318	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0004	0.00293	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000397	0.00291	CbGpPWpGaD
Lovastatin—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000394	0.00289	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000389	0.00285	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000372	0.00273	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000372	0.00272	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000355	0.0026	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000354	0.00259	CbGpPWpGaD
Lovastatin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000348	0.00255	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000346	0.00254	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000344	0.00252	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000342	0.0025	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—EP300—attention deficit hyperactivity disorder	0.000332	0.00244	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000331	0.00243	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00033	0.00242	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00033	0.00242	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000324	0.00238	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000319	0.00234	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000313	0.00229	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000309	0.00227	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000307	0.00225	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000307	0.00225	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000305	0.00224	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000303	0.00222	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000302	0.00221	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000288	0.00211	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EP300—attention deficit hyperactivity disorder	0.000288	0.00211	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000284	0.00208	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000282	0.00207	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000282	0.00207	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00028	0.00206	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00028	0.00205	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000278	0.00204	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000278	0.00204	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000276	0.00202	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000269	0.00197	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000269	0.00197	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000269	0.00197	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000266	0.00195	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000264	0.00194	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000264	0.00193	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000259	0.0019	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000252	0.00184	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000251	0.00184	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000247	0.00181	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000246	0.0018	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000229	0.00168	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000229	0.00168	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000226	0.00166	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000225	0.00165	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000217	0.00159	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000215	0.00158	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000209	0.00153	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.0015	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—COMT—attention deficit hyperactivity disorder	0.0002	0.00146	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000199	0.00146	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000199	0.00146	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000198	0.00145	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000196	0.00144	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000192	0.00141	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00019	0.00139	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000186	0.00136	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000186	0.00136	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000186	0.00136	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000185	0.00135	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000183	0.00134	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000183	0.00134	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000183	0.00134	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000182	0.00133	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000176	0.00129	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.00128	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000171	0.00125	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00017	0.00125	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00017	0.00125	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00017	0.00125	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000169	0.00124	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.00123	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000167	0.00123	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000166	0.00121	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000164	0.0012	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000163	0.00119	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000162	0.00119	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000159	0.00117	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000156	0.00114	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000156	0.00114	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000156	0.00114	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000154	0.00113	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000154	0.00113	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.00111	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000148	0.00109	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.00105	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000142	0.00104	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000141	0.00104	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000138	0.00102	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000137	0.00101	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000136	0.000997	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00095	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00013	0.000949	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000126	0.000927	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000915	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000123	0.000905	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000121	0.000884	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00012	0.000878	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000119	0.000873	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000871	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000116	0.000853	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000116	0.000851	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000115	0.000845	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000113	0.000828	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000113	0.000828	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000113	0.000825	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000112	0.000819	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000111	0.000814	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000108	0.000792	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000103	0.000757	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000103	0.000756	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000102	0.000751	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.93e-05	0.000728	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	9.78e-05	0.000717	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.78e-05	0.000717	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	9.62e-05	0.000705	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	9.46e-05	0.000694	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	9.4e-05	0.000689	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.03e-05	0.000662	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.94e-05	0.000656	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	8.73e-05	0.00064	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.73e-05	0.00064	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.59e-05	0.00063	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.59e-05	0.00063	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—EP300—attention deficit hyperactivity disorder	8.57e-05	0.000628	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.52e-05	0.000625	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.52e-05	0.000625	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.38e-05	0.000614	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EP300—attention deficit hyperactivity disorder	8.18e-05	0.000599	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.03e-05	0.000589	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.03e-05	0.000589	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.98e-05	0.000585	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	7.96e-05	0.000583	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.96e-05	0.000583	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.9e-05	0.000579	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	7.83e-05	0.000574	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.82e-05	0.000573	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.79e-05	0.000571	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.6e-05	0.000557	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.44e-05	0.000546	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.34e-05	0.000538	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.28e-05	0.000534	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—attention deficit hyperactivity disorder	6.98e-05	0.000512	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.98e-05	0.000512	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	6.84e-05	0.000501	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.81e-05	0.000499	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	6.79e-05	0.000498	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.64e-05	0.000487	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.48e-05	0.000475	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.42e-05	0.00047	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.36e-05	0.000466	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.11e-05	0.000448	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.06e-05	0.000444	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	5.94e-05	0.000435	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	5.92e-05	0.000434	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	5.88e-05	0.000431	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.73e-05	0.00042	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.7e-05	0.000418	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.29e-05	0.000388	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.25e-05	0.000385	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.25e-05	0.000385	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.25e-05	0.000385	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.17e-05	0.000379	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.16e-05	0.000379	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.16e-05	0.000378	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.12e-05	0.000376	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.09e-05	0.000373	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.86e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.83e-05	0.000354	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.82e-05	0.000354	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.82e-05	0.000353	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.8e-05	0.000352	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.79e-05	0.000351	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.64e-05	0.00034	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	4.42e-05	0.000324	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.2e-05	0.000308	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	4.06e-05	0.000297	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.99e-05	0.000293	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.18e-05	0.000233	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.16e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	2.93e-05	0.000215	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	2.54e-05	0.000186	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.27e-05	0.000166	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.21e-05	0.000162	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.09e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.07e-05	0.000152	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.36e-05	0.0001	CbGpPWpGaD
